Sk Biopharmaceuticals Co., Ltd. (326030)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
69,400. 00
-900
-1.2802%
₩
10.95T Market Cap
- P/E Ratio
- Div Yield
136,126 Volume
566.84 Eps
₩ 70,300
Previous Close Want to track 326030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sk Biopharmaceuticals Co., Ltd. (326030) Statistics
Valuation metrics
Market Cap 10.95T
Enterprise value 5.36T
Trailing P/E (ttm) 14.7
Forward P/E -
PEG ratio 0.29
Price/Sales (ttm) 6.61
Price/Book (mrq) 5.57
Enterprise Value/Revenue 6.23
Enterprise Value/EBITDA 22.72
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 93.4K
Average volume (90 days) 126.55K
Price summary
52-Week low 67,800
52-Week high 144,100
Beta -
50-Day moving average 81,200
200-Day moving average 88,405.6
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.47%
Operating margin 0.35%
Operational effectiveness
Return on assets 0.28%
Return on equity 0.47%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 10,998.68
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 5,119.92
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4,876.24
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 2.72%
Book value per share (mrq) 13,047.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
